title: Targeting EGFR in head and neck cancer: a decade of progress.
authors.forename: Chris
authors.initials: C
authors.lastname: Boshoff
authors.forename: Marshall
authors.initials: M
authors.lastname: Posner
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D000068818:Cetuximab; D002945:Cisplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D066246:ErbB Receptors / Q000187:drug effects*; D005472:Fluorouracil / Q000008:administration & dosage; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000191:economics / Q000378:metabolism*; D006801:Humans; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D066246:ErbB Receptors; D000068818:Cetuximab; D002945:Cisplatin; D005472:Fluorouracil